BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27714157)

  • 21. Synthesis, biochemical evaluation, and molecular modeling studies of aryl and arylalkyl di-n-butyl phosphates, effective butyrylcholinesterase inhibitors.
    Nakayama K; Schwans JP; Sorin EJ; Tran T; Gonzalez J; Arteaga E; McCoy S; Alvarado W
    Bioorg Med Chem; 2017 Jun; 25(12):3171-3181. PubMed ID: 28416102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation.
    Karlsson D; Fallarero A; Brunhofer G; Guzik P; Prinz M; Holzgrabe U; Erker T; Vuorela P
    Eur J Pharm Sci; 2012 Jan; 45(1-2):169-83. PubMed ID: 22108346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isosteroidal alkaloids as potent dual-binding site inhibitors of both acetylcholinesterase and butyrylcholinesterase from the bulbs of Fritillaria walujewii.
    Liu YM; Feng YD; Lu X; Nie JB; Li W; Wang LN; Tian LJ; Liu QH
    Eur J Med Chem; 2017 Sep; 137():280-291. PubMed ID: 28605675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes.
    Pajk S; Knez D; Košak U; Zorović M; Brazzolotto X; Coquelle N; Nachon F; Colletier JP; Živin M; Stojan J; Gobec S
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):498-505. PubMed ID: 31914836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.
    Catto M; Berezin AA; Lo Re D; Loizou G; Demetriades M; De Stradis A; Campagna F; Koutentis PA; Carotti A
    Eur J Med Chem; 2012 Dec; 58():84-97. PubMed ID: 23108363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative enzymatic studies using ion-selective electrodes. The case of cholinesterases.
    Cuartero M; Pérez S; García MS; García-Cánovas F; Ortuño JA
    Talanta; 2018 Apr; 180():316-322. PubMed ID: 29332816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, biological evaluation and docking studies of 2,3-dihydroquinazolin-4(1H)-one derivatives as inhibitors of cholinesterases.
    Sarfraz M; Sultana N; Rashid U; Akram MS; Sadiq A; Tariq MI
    Bioorg Chem; 2017 Feb; 70():237-244. PubMed ID: 28126287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, structure-activity relationship and molecular docking of 3-oxoaurones and 3-thioaurones as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Mughal EU; Sadiq A; Murtaza S; Rafique H; Zafar MN; Riaz T; Khan BA; Hameed A; Khan KM
    Bioorg Med Chem; 2017 Jan; 25(1):100-106. PubMed ID: 27780618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
    Pacheco G; Palacios-Esquivel R; Moss DE
    J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resurfaced fluorescent protein as a sensing platform for label-free detection of copper(II) ion and acetylcholinesterase activity.
    Lei C; Wang Z; Nie Z; Deng H; Hu H; Huang Y; Yao S
    Anal Chem; 2015 Feb; 87(3):1974-80. PubMed ID: 25560517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Miniaturization and validation of the Ellman's reaction based acetylcholinesterase inhibitory assay into 384-well plate format and screening of a chemical library.
    Järvinen PP; Fallarero A; Gupta S; Mohan GC; Hatakka AI; Vuorela PM
    Comb Chem High Throughput Screen; 2010 Mar; 13(3):278-84. PubMed ID: 20230371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulated dye retention for the signal-on fluorometric determination of acetylcholinesterase inhibitor.
    Liao S; Han W; Ding H; Xie D; Tan H; Yang S; Wu Z; Shen G; Yu R
    Anal Chem; 2013 May; 85(10):4968-73. PubMed ID: 23597308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine.
    Bitzinger DI; Gruber M; Tümmler S; Michels B; Bundscherer A; Hopf S; Trabold B; Graf BM; Zausig YA
    Neuropharmacology; 2016 Oct; 109():1-6. PubMed ID: 26772968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, characterization and in vitro evaluation of substituted N-(2-phenylcyclopropyl)carbamates as acetyl- and butyrylcholinesterase inhibitors.
    Horáková E; Drabina P; Brož B; Štěpánková Š; Vorčáková K; Královec K; Havelek R; Sedlák M
    J Enzyme Inhib Med Chem; 2016; 31(sup3):173-179. PubMed ID: 27476673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gold nanoclusters-Cu(2+) ensemble-based fluorescence turn-on and real-time assay for acetylcholinesterase activity and inhibitor screening.
    Sun J; Yang X
    Biosens Bioelectron; 2015 Dec; 74():177-82. PubMed ID: 26141104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation, anticholinesterase activity and molecular docking of new lupane derivatives.
    Castro MJ; Richmond V; Romero C; Maier MS; Estévez-Braun A; Ravelo AG; Faraoni MB; Murray AP
    Bioorg Med Chem; 2014 Jul; 22(13):3341-50. PubMed ID: 24835788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetylcholinesterase and butyrylcholinesterase activities in obese Beagle dogs before and after weight loss.
    Tvarijonaviciute A; Ceron JJ; Tecles F
    Vet Clin Pathol; 2013 Jun; 42(2):207-11. PubMed ID: 23550593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of 3-thiazolocoumarinyl Schiff-base derivatives as cholinesterase inhibitors.
    Raza R; Saeed A; Arif M; Mahmood S; Muddassar M; Raza A; Iqbal J
    Chem Biol Drug Des; 2012 Oct; 80(4):605-15. PubMed ID: 22726458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
    Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
    Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amino derivatives of platanic acid act as selective and potent inhibitors of butyrylcholinesterase.
    Heller L; Kahnt M; Loesche A; Grabandt P; Schwarz S; Brandt W; Csuk R
    Eur J Med Chem; 2017 Jan; 126():652-668. PubMed ID: 27936444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.